Capvizr
THE DEAL, AT A GLANCE

OSMUNDA

1/4 reviewed
01What it doesOSMUNDA offers support for developing medical device businesses.Source-grounded · automated review · Explore ↗

Checked 2026-11-14 · Review due 2026-11-21

Read supporting source ↗
如果你有寻找医疗器械孵化, 那就与我们取得联系吧!…
02Who is involvedBacked by Sequoia, FactoryFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedOSMUNDA raised Series D, announced 2026-11-13From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersOSMUNDA's reported Series D thesis depends on whether a device factory and AI platform can be developed into a viable combined offering.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

OSMUNDA · Financing Record

Explore source-linked visual explanations for OSMUNDA. Unsupported claims are withheld while source review continues.

Record 15951 · Recorded date: 2026-11-13

What it does

OSMUNDA: illustrative category image
Illustrative image (software ui), not OSMUNDA's product · Telmo E Silva / CC BY-SA 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 15951 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime